Generic Name and Formulations:
Pramoxine HCl 1%, hydrocortisone acetate 1%; aerosol foam.
Indications for PROCTOFOAM-HC:
Steroid-responsive anogenital dermatoses.
Apply 3–4 times daily.
Apply least amount compatible with therapeutic regimen.
Tuberculosis. Diverticulitis. Treat infection if present. Significant systemic absorption may occur. Discontinue if no improvement in 2–3 weeks. Children. Vaccinations. Pregnancy (Cat.C). Nursing mothers.
Anesthetic + steroid.
Adrenal suppression, dermal and epidermal atrophy, poor wound healing, local irritation: folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, macerations, secondary infections, striae, miliaria.
Aerosol—10g (w. applicator)
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|